NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
| Author | |
|---|---|
| Abstract |
:
A new biomarker, suppression of tumorigenicity 2 (ST2) has been introduced as a marker for fibrosis and hypertrophy. Its clinical value in comparison with NTproBNP in predicting mortality in elderly patients with symptoms of heart failure (HF) is still unclear. |
| Year of Publication |
:
2018
|
| Journal |
:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
|
| Number of Pages |
:
1-19
|
| Date Published |
:
2018
|
| ISSN Number |
:
1354-750X
|
| URL |
:
http://www.tandfonline.com/doi/full/10.1080/1354750X.2018.1431692
|
| DOI |
:
10.1080/1354750X.2018.1431692
|
| Short Title |
:
Biomarkers
|
| Download citation |
